CMS Open Payments data for 2014 is now available and includes information on 11.4 million financial transactions attributed to over 600,000 physicians and more than 1100 teaching hospitals, totaling $6.49 billion.
Data on transfer of value by drug and medical device makers to healthcare providers from 2014 are now available on CMS' Open Payments. The data includes information on 11.4 million financial transactions attributed to over 600,000 physicians and more than 1100 teaching hospitals, totaling $6.49 billion.
CMS has validated 98.8% of all records submitted in the Open Payments system for 2013 and 2014. Records that could not be verified were rejected and not processed.
“Consumer access to information is a key component of delivery system reform and making the healthcare system perform better," Acting CMS Administrator Andy Slavitt, said in a statement. "In year 2, Open Payments is now a highly searchable resource to provide transparency to over 1-and-a-half years’ worth of financial transactions between drug and device companies and physicians and teaching hospitals. This is part of our larger effort to open up the healthcare system to consumers by providing more information to help in their decision making.”
While the American Medical Association (AMA) applauds CMS' efforts of transparency, it experssed concern that the majority of information released through Open Payments was not independently validated by physicians. In addition, the Association pointed out that the process for physicians to review their data and seek to correct any inaccuracies is complicated and cumbersome.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Insurance Gaps Threaten Cancer Treatment Success
July 7th 2025Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and under optimal circumstances, continue to top the list of reasons behind outcomes disparities for patients who have private insurance vs those who remain uninsured.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More